DK1140020T3 - Lægemiddelleveringssystem til levering af store molekyler ved anvendelse af membranefterlignende amfifile stoffer på aerosolform - Google Patents
Lægemiddelleveringssystem til levering af store molekyler ved anvendelse af membranefterlignende amfifile stoffer på aerosolformInfo
- Publication number
- DK1140020T3 DK1140020T3 DK99962011T DK99962011T DK1140020T3 DK 1140020 T3 DK1140020 T3 DK 1140020T3 DK 99962011 T DK99962011 T DK 99962011T DK 99962011 T DK99962011 T DK 99962011T DK 1140020 T3 DK1140020 T3 DK 1140020T3
- Authority
- DK
- Denmark
- Prior art keywords
- membrane
- aerosol
- large molecule
- amphiphilic substances
- delivery system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11324298P | 1998-12-21 | 1998-12-21 | |
US09/397,701 US6271200B1 (en) | 1998-12-21 | 1999-09-16 | Proteinic drug delivery system using aerosolized membrane-mimetic amphiphiles |
PCT/CA1999/001233 WO2000037053A1 (en) | 1998-12-21 | 1999-12-16 | Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1140020T3 true DK1140020T3 (da) | 2004-07-12 |
Family
ID=26810842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK99962011T DK1140020T3 (da) | 1998-12-21 | 1999-12-16 | Lægemiddelleveringssystem til levering af store molekyler ved anvendelse af membranefterlignende amfifile stoffer på aerosolform |
Country Status (11)
Country | Link |
---|---|
US (1) | US6271200B1 (da) |
EP (1) | EP1140020B1 (da) |
JP (1) | JP2004537493A (da) |
AT (1) | ATE260643T1 (da) |
AU (1) | AU1852000A (da) |
CA (1) | CA2353848A1 (da) |
DE (1) | DE69915347T2 (da) |
DK (1) | DK1140020T3 (da) |
MX (1) | MXPA01006379A (da) |
NZ (1) | NZ512046A (da) |
WO (1) | WO2000037053A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6290987B1 (en) * | 1998-09-27 | 2001-09-18 | Generex Pharmaceuticals, Inc. | Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
US6451286B1 (en) * | 1998-12-21 | 2002-09-17 | Generex Pharmaceuticals Incorporated | Pharmaceutical compositions for buccal and pulmonary administration comprising an alkali metal alkyl sulfate and at least three micelle-forming compounds |
US6849263B2 (en) * | 1998-12-21 | 2005-02-01 | Generex Pharmaceutical Incorporated | Pharmaceutical compositions for buccal delivery of pain relief medications |
US7087215B2 (en) * | 1998-12-21 | 2006-08-08 | Generex Pharmaceuticals Incorporated | Methods of administering and enhancing absorption of pharmaceutical agents |
US6350432B1 (en) * | 1999-03-19 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Pressurized container having an aerosolized pharmaceutical composition |
FR2798288B1 (fr) * | 1999-09-14 | 2001-11-30 | Capsulis | Compositions vaccinales destinees a une administration par voie muqueuse |
FR2806913B1 (fr) * | 2000-03-31 | 2003-01-31 | Pf Medicament | Utilisation d'ammoniums quaternaires aliphatiques comme adjuvant dans une composition pharmaceutique administrable par voie mucosale |
WO2002022151A2 (en) | 2000-09-18 | 2002-03-21 | Osteometer Bio Tech A/S | Use of glp-1 and flp-2 peptides for treatment of bone disorders |
US7371721B2 (en) | 2000-09-18 | 2008-05-13 | Sanos Bioscience A/S | Use of GLP-2 and related compounds for the treatment, prevention, diagnosis, and prognosis of bone-related disorders and calcium homeostasis related syndromes |
CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7335686B2 (en) * | 2003-10-20 | 2008-02-26 | Council Of Scientific And Industrial Research | Method and composition for treating osteoporosis |
US20100297249A1 (en) * | 2007-07-05 | 2010-11-25 | North-West University | Enhancement of the efficacy of therapeutic proteins |
EP2039360A1 (en) * | 2007-09-19 | 2009-03-25 | Euro-Celtique S.A. | Non-invasive direct delivery of opioids to the central nervous system |
US20100291160A1 (en) * | 2009-05-13 | 2010-11-18 | Carver David R | Pharmaceutical system for trans-membrane delivery |
US9445992B2 (en) | 2009-11-25 | 2016-09-20 | Arisgen Sa | Mucosal delivery compositions comprising a peptide complexed with a crown compound and/or a counter ion |
CN102988294B (zh) * | 2012-12-13 | 2015-03-11 | 上海纳米技术及应用国家工程研究中心有限公司 | 一种氟碳化合物脂质体的制备方法 |
WO2019129761A1 (en) * | 2017-12-27 | 2019-07-04 | Ursapharm Arzneimittel Gmbh | Compositions and methods for eye and nose care |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2408387A2 (fr) | 1975-06-30 | 1979-06-08 | Oreal | Compositions a base de dispersions aqueuses de spherules lipidiques |
US4900730A (en) | 1981-01-14 | 1990-02-13 | Toyo Jozo Co., Ltd. | Preparation which promotes the absorption of peptides |
NL193099C (nl) | 1981-10-30 | 1998-11-03 | Novo Industri As | Gestabiliseerde insuline-oplossing. |
US4708861A (en) | 1984-02-15 | 1987-11-24 | The Liposome Company, Inc. | Liposome-gel compositions |
EP0158441B2 (en) | 1984-03-08 | 2001-04-04 | Phares Pharmaceutical Research N.V. | Liposome-forming composition |
FR2571963B1 (fr) | 1984-10-24 | 1987-07-10 | Oreal | Composition a usage cosmetique ou pharmaceutique contenant des niosomes et au moins un polyamide hydrosoluble et procede de preparation de cette composition. |
EP0200383A3 (en) | 1985-04-15 | 1987-09-02 | Eli Lilly And Company | An improved method for administering insulin |
US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
NZ222907A (en) | 1986-12-16 | 1990-08-28 | Novo Industri As | Preparation for intranasal administration containing a phospholipid absorption enhancing system |
US4839111A (en) | 1987-02-02 | 1989-06-13 | The University Of Tennessee Research Corporation | Preparation of solid core liposomes |
US5234767A (en) | 1987-03-13 | 1993-08-10 | Micro-Pak, Inc. | Hybrid paucilamellar lipid vesicles |
US5147723A (en) | 1987-07-28 | 1992-09-15 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
US5690954A (en) | 1987-05-22 | 1997-11-25 | Danbiosyst Uk Limited | Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material |
CA2033725C (en) | 1990-01-24 | 2001-05-29 | Folker Pittrof | Pharmaceutical and cosmetic compositions containing a salt of cholanic acid |
GB9007052D0 (en) | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
US5292499A (en) | 1990-09-11 | 1994-03-08 | University Of Wales College Of Cardiff | Method of preparing medical aerosol formulations including drug dissolved in reverse micelles |
US5230884A (en) | 1990-09-11 | 1993-07-27 | University Of Wales College Of Cardiff | Aerosol formulations including proteins and peptides solubilized in reverse micelles and process for making the aerosol formulations |
US5416071A (en) | 1991-03-12 | 1995-05-16 | Takeda Chemical Industries, Ltd. | Water-soluble composition for sustained-release containing epo and hyaluronic acid |
US5260065A (en) | 1991-09-17 | 1993-11-09 | Micro Vesicular Systems, Inc. | Blended lipid vesicles |
US5643600A (en) | 1991-09-17 | 1997-07-01 | Micro-Pak, Inc. | Lipid vesicles containing avocado oil unsaponifiables |
US5514670A (en) | 1993-08-13 | 1996-05-07 | Pharmos Corporation | Submicron emulsions for delivery of peptides |
US5653987A (en) * | 1995-05-16 | 1997-08-05 | Modi; Pankaj | Liquid formulations for proteinic pharmaceuticals |
PL323931A1 (en) | 1995-06-07 | 1998-04-27 | Alliance Pharma | Compositions of reversed emulsion of fluorine derivatives of hydrocarbons for use as drug delivering carriers |
US5891465A (en) | 1996-05-14 | 1999-04-06 | Biozone Laboratories, Inc. | Delivery of biologically active material in a liposomal formulation for administration into the mouth |
US6017545A (en) * | 1998-02-10 | 2000-01-25 | Modi; Pankaj | Mixed micellar delivery system and method of preparation |
-
1999
- 1999-09-16 US US09/397,701 patent/US6271200B1/en not_active Expired - Lifetime
- 1999-12-16 NZ NZ512046A patent/NZ512046A/en not_active IP Right Cessation
- 1999-12-16 EP EP99962011A patent/EP1140020B1/en not_active Expired - Lifetime
- 1999-12-16 DE DE69915347T patent/DE69915347T2/de not_active Expired - Lifetime
- 1999-12-16 WO PCT/CA1999/001233 patent/WO2000037053A1/en active IP Right Grant
- 1999-12-16 MX MXPA01006379A patent/MXPA01006379A/es not_active IP Right Cessation
- 1999-12-16 CA CA002353848A patent/CA2353848A1/en not_active Abandoned
- 1999-12-16 AU AU18520/00A patent/AU1852000A/en not_active Abandoned
- 1999-12-16 AT AT99962011T patent/ATE260643T1/de not_active IP Right Cessation
- 1999-12-16 JP JP2000589164A patent/JP2004537493A/ja active Pending
- 1999-12-16 DK DK99962011T patent/DK1140020T3/da active
Also Published As
Publication number | Publication date |
---|---|
DE69915347D1 (de) | 2004-04-08 |
CA2353848A1 (en) | 2000-06-29 |
MXPA01006379A (es) | 2002-04-24 |
EP1140020B1 (en) | 2004-03-03 |
US6271200B1 (en) | 2001-08-07 |
ATE260643T1 (de) | 2004-03-15 |
JP2004537493A (ja) | 2004-12-16 |
WO2000037053A1 (en) | 2000-06-29 |
NZ512046A (en) | 2002-04-26 |
DE69915347T2 (de) | 2005-05-04 |
AU1852000A (en) | 2000-07-12 |
EP1140020A1 (en) | 2001-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1140020T3 (da) | Lægemiddelleveringssystem til levering af store molekyler ved anvendelse af membranefterlignende amfifile stoffer på aerosolform | |
AU4711296A (en) | Method for loading lipid vesicles | |
DK0993831T3 (da) | Forbindelser og præparater til tilförsel af aktive stoffer | |
DE69730218D1 (de) | Fusogene liposomen | |
AU3559895A (en) | Polyethylene glycol modified ceramide lipids and liposome uses thereof | |
DK0831779T3 (da) | Fremgangsmåde til fremstilling af liposompræparat | |
ATE172636T1 (de) | Liposomales verabreichungssystem für biologisch aktive stoffe | |
ES2085936T3 (es) | Preparado para aplicar sustancias activas en forma de microgotas. | |
AU6675198A (en) | Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use | |
BR9809328A (pt) | Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa | |
AR013442A1 (es) | Proceso para preparar una dispersion de politetrafluroetileno. | |
HK1031197A1 (en) | Osmotic dosage form comprising first and second coats | |
ATE286718T1 (de) | Temperatursensitive liposomale formulierung | |
EE04273B1 (et) | Bensotsüklohepteenid, nende valmistamise meetod, neid sisaldavad farmatseutilised preparaadid ja nende kasutamine ravimite valmistamiseks | |
DK0680750T3 (da) | Kosmetisk eller farmaceutisk sammensætning til topisk anvendelse | |
ATE172638T1 (de) | Ein neues arzneimittelabgabesystem | |
TR200100366T2 (tr) | Aktif madde dağıtmaya mahsus bileşikler ve bileşimler. | |
AR002009A1 (es) | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. | |
ATE284204T1 (de) | Lipidkomplexe von sehr unlöslichen platinkomplexen | |
ATE217532T1 (de) | Eine didemnin verbindung enthaltende pharmazeutische formulierung | |
AU1307399A (en) | Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same | |
AU4246296A (en) | Methods and apparatus for making liposomes containing hydrophobic drugs | |
DK1051158T3 (da) | Farmaceutiske præparater i form af polymere mikropartikler fremstillet ved ekstrudering og sfæronisering | |
ES2078510T3 (es) | Dispersion acuosa de vesiculas de fosfolipidos, procedimiento para su fabricacion y su uso. | |
CA2326348A1 (en) | Liposomal bupivacaine compositions and methods of preparation |